FDA 510(k)

Caphosol 人工唾液片

K号: K162167 · 2017-03-31

决定日期2017-03-31

产品代码LFD

决定实质等同

器械摘要

Caphosol Artifical Saliva Tablets is the device name listed in this FDA 510(k) record. The listed applicant is Eusa Pharma (Uk) Limited. It received FDA 510(k) clearance on 2017-03-31 under 510(k) number K162167. The device is classified under product code LFD. FDA Decision: Substantially Equivalent.

常见问题

What is the Caphosol Artifical Saliva Tablets?

Caphosol Artifical Saliva Tablets is a medical device that received FDA 510(k) clearance on 2017-03-31. The listed applicant is Eusa Pharma (Uk) Limited. The 510(k) number is K162167.

When did Caphosol Artifical Saliva Tablets receive FDA 510(k) clearance?

Caphosol Artifical Saliva Tablets received FDA 510(k) clearance on 2017-03-31, under 510(k) number K162167.

Who is the listed applicant for Caphosol Artifical Saliva Tablets?

The FDA 510(k) record lists Eusa Pharma (Uk) Limited as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for Caphosol Artifical Saliva Tablets?

The FDA product code for Caphosol Artifical Saliva Tablets is LFD.

列明Eusa Pharma (Uk) Limited为申报人的其他记录

关联记录通过名称、产品代码或其他元数据自动匹配。匹配不意味着已验证临床、科学、企业或监管关系；请查阅链接的官方来源。

K234015Caphosol® 人工唾液 (32 剂量袋装盒)

官方来源

在 FDA 数据库中查看 →

数据来源于FDA开放API。如需最新且权威的信息，请务必参考官方记录。